Home > Neurology > ECTRIMS 2021 > Introduction


Prof. Hans-Peter Hartung , Heinrich-Heine-University Düsseldorf, Germany
Dear Reader, ECTRIMS 2021 originally planned to take place in Vienna, the premier annual event convening researchers, clinicians and other healthcare providers interested and involved in MS and related disorders such as NMOSD or MOGAD, for the second time was entirely virtual. It  provided a fully digital experience to disseminate the latest and exciting topics in MS research to the world. The extensive scientific programme included talks and e-posters on a broad range of clinical developments, pathology and pathogenesis of the disease, novel biomarkers, and, of course, treatments - from phase 1 through phase 4 trials, real world observations and comprehensive registry data. Very topically the impact of COVID-19 on MS and its management was extensively discussed. This Conference Report aims to contribute to the dissemination. We have summarised a selection of presentations covering all topics mentioned. The long-awaited update of the ECTRIMS/EAN joint guideli...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on